Group( D )

......... often arises in areas of endothelial damage or dysfunction, such as atherosclerotic plaques? السابعه ✨.

..... Quantitative tests for clotting factors (e.g., factor VIII level in hemophilia A). مهمه

....... Assesses the intrinsic pathway.

....... Evaluates the extrinsic and common coagulation pathways. مهمه

.......Assesses platelet count and overall blood cell health.

......... render blood vessels fragile, predisposing patients to bleeding despite intact clotting systems. مهمه

......... low platelet count, which can be due to bone marrow disorders or immune-mediated destruction?

Platelet Abnormalities:

....... result in platelets that fail to aggregate or adhere properly?

von Willebrand Disease ،Hemophilia A and B :

Reduced quantity or dysfunction of von Willebrand factor (vWF) impairs platelet adhesion and secondary stabilization of factor VIII, resulting lead .....

Hemophilia A and B Deficiencies in clotting factors VIII and IX, respectively, typically to lead......مهمه

....... The eventual breakdown of the clot once vessel repair has been achieved. مهمه

....... Activation of the coagulation cascade that stabilizes the initial plug with fibrin strands?

........ Immediate vascular constriction and formation of a platelet plug?

The process of hemostasis is a coordinated series of events involving:

....... Conditions that develop later in life due to external factors, such as medications (anticoagulants)?

......... Genetic conditions that impair clotting factor production or platelet function?

......... (e.g., frequent nosebleeds, gum bleeding) ?

.......... seen in severe coagulopathies ?